ML

Mrs Megan Lawrence

Senior Medical Statistician

Connect with Megan

Email: m.m.lawrence@soton.ac.uk

Publications

2 publications

Page 1 of 1

An open label, adaptive, phase 1 trial of high-dose oral nitazoxanide in healthy volunteers

,

Lauren E. Walker,

Richard FitzGerald,

Geoffrey Saunders,

Rebecca Lyon,

Michael Fisher,

Karen Martin,

Izabela Eberhart,

Christie Woods,

Sean Ewings,

Colin Hale,

Rajith Kr Rajoli,

Laura Else,

Sujan Dilly-Penchala,

Alieu Amara,

David G Lalloo,

Michael Jacobs,

Henry Pertinez,

Parys Hatchard,

Robert Waugh,

Megan Lawrence,

Lucy Johnson,

Keira Fines,

Helen Reynolds,

Timothy Rowland,

Rebecca Crook,

Emmanuel Okenyi,

Kelly Byrne,

Pavel Mozgunov,

Thomas Jaki,

Saye Khoo,

Andrew Owen,

Gareth Griffiths,

& Thomas E Fletcher

, 2021 , Clinical Pharmacology and Therapeutics

DOI: 10.1002/cpt.2463

Type: article

9p gain predicts outcomes in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) treated with R-GemOx +/- Atezolizumab. ARGO: a randomised phase II study

A. Davies,

P. Mckay,

W. Osborne,

L. Stanton,

O. Tansley‐hancock,

M. Lawrence,

K. Mercer,

A. Allen,

B. Pottinger,

A. Zhelyazkova,

F. Miall,

J. Rafferty,

B. Sale,

F. Cucco,

L. Nunn,

A. Coleman,

G. Griffiths,

M. Q Du,

C. Burton,

S. Barrons,

& P. Johnson

, 2021 , Hematological Oncology , 39 (S2) , 155 -- 156

DOI: 10.1002/hon.11_2880

Type: conference

How to edit profile

Back to top